1149 related articles for article (PubMed ID: 22495321)
1. The genetic architecture of multiple myeloma.
Morgan GJ; Walker BA; Davies FE
Nat Rev Cancer; 2012 Apr; 12(5):335-48. PubMed ID: 22495321
[TBL] [Abstract][Full Text] [Related]
2. Subclonal evolution in disease progression from MGUS/SMM to multiple myeloma is characterised by clonal stability.
Dutta AK; Fink JL; Grady JP; Morgan GJ; Mullighan CG; To LB; Hewett DR; Zannettino ACW
Leukemia; 2019 Feb; 33(2):457-468. PubMed ID: 30046162
[TBL] [Abstract][Full Text] [Related]
3. Single-cell profiling of tumour evolution in multiple myeloma - opportunities for precision medicine.
Dutta AK; Alberge JB; Sklavenitis-Pistofidis R; Lightbody ED; Getz G; Ghobrial IM
Nat Rev Clin Oncol; 2022 Apr; 19(4):223-236. PubMed ID: 35017721
[TBL] [Abstract][Full Text] [Related]
4. Circulating Tumour DNA Analysis for Tumour Genome Characterisation and Monitoring Disease Burden in Extramedullary Multiple Myeloma.
Mithraprabhu S; Sirdesai S; Chen M; Khong T; Spencer A
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29937522
[TBL] [Abstract][Full Text] [Related]
5. Genomic complexity of multiple myeloma and its clinical implications.
Manier S; Salem KZ; Park J; Landau DA; Getz G; Ghobrial IM
Nat Rev Clin Oncol; 2017 Feb; 14(2):100-113. PubMed ID: 27531699
[TBL] [Abstract][Full Text] [Related]
6. Plasma cells expression from smouldering myeloma to myeloma reveals the importance of the PRC2 complex, cell cycle progression, and the divergent evolutionary pathways within the different molecular subgroups.
Boyle EM; Rosenthal A; Ghamlouch H; Wang Y; Farmer P; Rutherford M; Ashby C; Bauer M; Johnson SK; Wardell CP; Wang Y; Hoering A; Schinke C; Thanendrarajan S; Zangari M; Barlogie B; Dhodapkar MV; Davies FE; Morgan GJ; van Rhee F; Walker BA
Leukemia; 2022 Feb; 36(2):591-595. PubMed ID: 34365473
[TBL] [Abstract][Full Text] [Related]
7. Myeloid transformation of plasma cell myeloma: molecular evidence of clonal evolution revealed by next generation sequencing.
Gralewski JH; Post GR; van Rhee F; Yuan Y
Diagn Pathol; 2018 Feb; 13(1):15. PubMed ID: 29463311
[TBL] [Abstract][Full Text] [Related]
8. Darwinian evolution and tiding clones in multiple myeloma.
Bahlis NJ
Blood; 2012 Aug; 120(5):927-8. PubMed ID: 22859708
[TBL] [Abstract][Full Text] [Related]
9. Centrosome amplification and clonal evolution in multiple myeloma: Short review.
Kryukova E; Kryukov F; Hajek R
Crit Rev Oncol Hematol; 2016 Feb; 98():116-21. PubMed ID: 26589397
[TBL] [Abstract][Full Text] [Related]
10. Role of AID in the temporal pattern of acquisition of driver mutations in multiple myeloma.
Maura F; Rustad EH; Yellapantula V; Łuksza M; Hoyos D; Maclachlan KH; Diamond BT; Greenbaum BD; Morgan G; Lesokhin A; Papaemmanuil E; Landgren O
Leukemia; 2020 May; 34(5):1476-1480. PubMed ID: 31836853
[No Abstract] [Full Text] [Related]
11. Towards Stratified Medicine in Plasma Cell Myeloma.
Egan P; Drain S; Conway C; Bjourson AJ; Alexander HD
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775669
[TBL] [Abstract][Full Text] [Related]
12. Clonal Evolution in Multiple Myeloma.
Fakhri B; Vij R
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S130-4. PubMed ID: 27521309
[TBL] [Abstract][Full Text] [Related]
13. The role of clonal evolution in smoldering multiple myeloma.
Bhatnagar V; Badros A
Leuk Lymphoma; 2014 Feb; 55(2):464-6. PubMed ID: 23865829
[No Abstract] [Full Text] [Related]
14. Genomic discovery and clonal tracking in multiple myeloma by cell-free DNA sequencing.
Guo G; Raje NS; Seifer C; Kloeber J; Isenhart R; Ha G; Yee AJ; O'Donnell EK; Tai YT; Richardson PG; Bianchi G; Laubach JP; Warren D; Gemme E; Voisine J; Frede J; Kokkalis A; Yun H; Dimitrova V; Vijaykumar T; Meyerson M; Munshi NC; Anderson KC; Knoechel B; Lohr JG
Leukemia; 2018 Aug; 32(8):1838-1841. PubMed ID: 29749395
[No Abstract] [Full Text] [Related]
15. Cutting edge genomics reveal new insights into tumour development, disease progression and therapeutic impacts in multiple myeloma.
Dutta AK; Hewett DR; Fink JL; Grady JP; Zannettino ACW
Br J Haematol; 2017 Jul; 178(2):196-208. PubMed ID: 28466550
[TBL] [Abstract][Full Text] [Related]
16. The cellular architecture of multiple myeloma.
Vicente-Dueñas C; Romero-Camarero I; García-Criado FJ; Cobaleda C; Sánchez-García I
Cell Cycle; 2012 Oct; 11(20):3715-7. PubMed ID: 22983005
[No Abstract] [Full Text] [Related]
17. Impact of Clonal Heterogeneity in Multiple Myeloma.
Schinke C; Rasche L; Raab MS; Weinhold N
Hematol Oncol Clin North Am; 2024 Apr; 38(2):461-476. PubMed ID: 38195308
[TBL] [Abstract][Full Text] [Related]
18. [The pathology and genetic background of myeloma].
Timár B
Magy Onkol; 2016 Jun; 60(2):145-53. PubMed ID: 27275641
[TBL] [Abstract][Full Text] [Related]
19. Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing.
Rasche L; Chavan SS; Stephens OW; Patel PH; Tytarenko R; Ashby C; Bauer M; Stein C; Deshpande S; Wardell C; Buzder T; Molnar G; Zangari M; van Rhee F; Thanendrarajan S; Schinke C; Epstein J; Davies FE; Walker BA; Meissner T; Barlogie B; Morgan GJ; Weinhold N
Nat Commun; 2017 Aug; 8(1):268. PubMed ID: 28814763
[TBL] [Abstract][Full Text] [Related]
20. A cellular model for myeloma cell growth and maturation based on an intraclonal CD45 hierarchy.
Bataille R; Robillard N; Pellat-Deceunynck C; Amiot M
Immunol Rev; 2003 Aug; 194():105-11. PubMed ID: 12846811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]